| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
C-reactive protein serves as one of the most clinically significant acute-phase reactants in human biology, synthesized primarily by hepatocytes in response to inflammatory cytokines. As a pentameric member of the pentraxin family, CRP plays essential roles in innate immunity through complement activation and opsonization of pathogens. Its dramatic elevation during infection, tissue injury, and chronic inflammatory conditions has established CRP as an indispensable biomarker in both clinical diagnostics and inflammation research.
This recombinant monoclonal antibody, clone 23C11, offers researchers the reproducibility advantages inherent to sequence-defined recombinant production. Unlike traditional hybridoma-derived antibodies, recombinant technology ensures consistent performance across lots, eliminating the variability that can compromise longitudinal studies or assay standardization efforts. The human IgG1 isotype format and affinity-chromatography purification yield a reagent suitable for demanding quantitative applications.
Validation studies demonstrate reliable performance across multiple experimental platforms. Immunohistochemistry testing in paraffin-embedded human liver tissue, the primary site of CRP synthesis, confirms effective antigen detection using citrate buffer retrieval at dilutions of 1:50 to 1:200. Flow cytometry analysis using HepG2 hepatocellular carcinoma cells shows clear positive signal separation from isotype control, with fixed and permeabilized cells stained at 1:100 dilution, indicating suitability for intracellular CRP detection in this hepatic cell model. The antibody is additionally validated for ELISA applications.
This antibody supports investigations into inflammatory pathway mechanisms, cardiovascular disease risk assessment, infection biology, and hepatocyte function studies where reliable CRP detection is essential for meaningful experimental outcomes.
Email: support@cusabio.com
Distributors Worldwide